Fear of COVID-19 Diagnosis and Cannabis Use Patterns Among Adults with Chronic Health Conditions: Results from COVID-19 Cannabis Health Study.

IF 2.1 4区 医学 Q2 PSYCHOLOGY, CLINICAL
Bria-Necole A Diggs, Amrit Baral, WayWay Hlaing, Yue Pan, Marlene Camacho-Rivera, Johis Ortega, Denise C Vidot
{"title":"Fear of COVID-19 Diagnosis and Cannabis Use Patterns Among Adults with Chronic Health Conditions: Results from COVID-19 Cannabis Health Study.","authors":"Bria-Necole A Diggs, Amrit Baral, WayWay Hlaing, Yue Pan, Marlene Camacho-Rivera, Johis Ortega, Denise C Vidot","doi":"10.1080/02791072.2024.2421903","DOIUrl":null,"url":null,"abstract":"<p><p>Given the scarcity of literature regarding COVID-19 impacts on cannabis consumers with chronic illnesses who widely use cannabis to manage their health conditions, we aim to assess the effect of COVID-19 on cannabis use patterns among adults living with chronic diseases. Cannabis consumers with a chronic disease (<i>N</i> = 1,466) from COVID-19 Cannabis Health Study were included in this analysis. The primary outcomes were change in cannabis dosage, past 30-day cannabis usage, and change in route of cannabis administration, with the main exposure being self-reported fear of COVID-19 diagnosis. Significant differences were found between changes in cannabis dose by fear of COVID-19 diagnosis (<i>p</i> = .03) where 41.5% of adults fearing diagnosis reported an increase in their cannabis dosage since the pandemic. Multinomial logistic regression showed that individuals who feared COVID-19 diagnosis had 50% greater odds [aOR = 1.50, 95% CI: 1.02-2.24 of decreasing their cannabis in reference to their dose staying the same, than those without fear of COVID-19, adjusting for socio-demographics. Our findings highlight the significant association between fear of COVID-19 diagnosis and changes in cannabis usage patterns among adults with chronic diseases. This underscores the pandemic's impact on health-related behaviors and the role of cannabis as a coping mechanism during uncertain times.</p>","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"1-10"},"PeriodicalIF":2.1000,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of psychoactive drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/02791072.2024.2421903","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Given the scarcity of literature regarding COVID-19 impacts on cannabis consumers with chronic illnesses who widely use cannabis to manage their health conditions, we aim to assess the effect of COVID-19 on cannabis use patterns among adults living with chronic diseases. Cannabis consumers with a chronic disease (N = 1,466) from COVID-19 Cannabis Health Study were included in this analysis. The primary outcomes were change in cannabis dosage, past 30-day cannabis usage, and change in route of cannabis administration, with the main exposure being self-reported fear of COVID-19 diagnosis. Significant differences were found between changes in cannabis dose by fear of COVID-19 diagnosis (p = .03) where 41.5% of adults fearing diagnosis reported an increase in their cannabis dosage since the pandemic. Multinomial logistic regression showed that individuals who feared COVID-19 diagnosis had 50% greater odds [aOR = 1.50, 95% CI: 1.02-2.24 of decreasing their cannabis in reference to their dose staying the same, than those without fear of COVID-19, adjusting for socio-demographics. Our findings highlight the significant association between fear of COVID-19 diagnosis and changes in cannabis usage patterns among adults with chronic diseases. This underscores the pandemic's impact on health-related behaviors and the role of cannabis as a coping mechanism during uncertain times.

患有慢性疾病的成年人对 COVID-19 诊断和大麻使用模式的恐惧:COVID-19 大麻健康研究的结果。
鉴于有关 COVID-19 对广泛使用大麻来控制健康状况的慢性病大麻消费者影响的文献很少,我们旨在评估 COVID-19 对慢性病成人大麻使用模式的影响。COVID-19 大麻健康研究中患有慢性病的大麻消费者(人数 = 1,466)被纳入本次分析。主要结果是大麻用量的变化、过去 30 天的大麻使用量和大麻使用途径的变化,主要暴露因素是自我报告的对 COVID-19 诊断的恐惧。根据对 COVID-19 诊断的恐惧程度得出的大麻剂量变化之间存在显著差异(p = 0.03),41.5% 担心被诊断出 COVID-19 的成年人报告自大流行以来大麻剂量有所增加。多项式逻辑回归显示,在对社会人口统计学进行调整后,害怕被诊断出 COVID-19 的人比不害怕被诊断出 COVID-19 的人减少吸食大麻的几率高出 50%[aOR = 1.50,95% CI:1.02-2.24]。我们的研究结果凸显了对 COVID-19 诊断的恐惧与慢性病成人大麻使用模式的变化之间的重要关联。这凸显了大流行病对健康相关行为的影响,以及大麻在不确定时期作为一种应对机制的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.30
自引率
7.10%
发文量
62
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信